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Cellular starvation is typically a consequence of tissue injury that
disrupts the local blood supply but can also occur where cell
populations outgrow the local vasculature, as observed in solid
tumors. Cells react to nutrient deprivation by adapting their
metabolism, or, if starvation is prolonged, it can result in cell
death. Cell starvation also triggers adaptive responses, like angio-
genesis, that promote tissue reorganization and repair, but other
adaptive responses and their mediators are still poorly character-
ized. To explore this issue, we analyzed secretomes from glucose-
deprived cells, which revealed up-regulation of multiple cytokines
and chemokines, including IL-6 and IL-8, in response to starvation
stress. Starvation-induced cytokines were cell type-dependent, and
they were also released from primary epithelial cells. Most cytokines
were up-regulated in a manner dependent on NF-κB and the tran-
scription factor of the integrated stress response ATF4, which bound
directly to the IL-8 promoter. Furthermore, glutamine deprivation,
as well as the antimetabolic drugs 2-deoxyglucose and metformin,
also promoted the release of IL-6 and IL-8. Finally, some of the
factors released from starved cells induced chemotaxis of B cells, mac-
rophages, and neutrophils, suggesting that nutrient deprivation in the
tumor environment can serve as an initiator of tumor inflammation.
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Numerous pathological conditions involve nutrient starvation.Upon mild starvation, proliferating cells undergo growth
arrest and down-regulate their anabolic metabolism. Non-
proliferating tissues are also sensitive to nutrient restriction, and,
if starvation is prolonged, cells undergo cell death, which damages
the tissue in ischemic diseases, such as stroke and myocardial in-
farction. Tissue injury due to blunt force trauma or cuts also dis-
turbs nutrient flux, promoting hypoxia and starvation. This type of
injury, as well as ischemic damage, engages the wound-healing
response to promote tissue repair.
Solid tumor development is also accompanied by a microenvi-
ronment low in nutrients (1). When blood vessels are not delivering
enough oxygen or nutrients, an increase in vascular endothelial
growth factor (VEGF) and other proangiogenic molecules ensures
the growth of blood vessels. This response is also coopted by tumors
to cope with low oxygen and nutrients in a process known as neo-
angiogenesis that is associated with tumor invasion and metastasis
(2). While neoangiogenesis has been widely studied as a response to
hypoxia, several reports indicate that nutrient restriction evokes the
same angiogenic responses through the release of proangiogenic
factors (3, 4). Another well-characterized response to ischemia in
noncancerous tissues is inflammation, which is associated with re-
jection of transplanted ischemic organs and contributes to injury,
but also to tissue repair, in stroke and other ischemic diseases (5, 6).
Inflammation, in this context, is generally thought to be driven by
the necrotic cell death occurring in ischemic tissues due to the lack
of oxygen or nutrients. However, some reports suggest that nutrient
restriction, even without cell death, can be sufficient to promote the
synthesis and/or secretion of select proinflammatory cytokines
(7–9). This suggests that cells in solid tissues possess an evolution-
arily conserved program to react to starvation that involves en-
gagement of surrounding cells, including the stroma and resident
immune system, to counteract the damage.
We hypothesized that starving cells, including tumor cells,
promote adaptive responses to nutrient deprivation that go be-
yond angiogenesis and resemble a wound-healing response.
Starving cells could promote tissue reorganization to restore
nutrients and dispose of “waste” products like lactate. To iden-
tify possible cell–cell responses, we analyzed the secretome of
starved cells and found that the release of inflammatory cyto-
kines and chemokines is a primary response to starvation in
multiple cancer cell types, which has implications in cancer im-
munity and for treatment with antimetabolic drugs.
Results
Cells Subjected to Glucose Deprivation Release Immune Cytokines
and Chemokines. We hypothesized that a reduction in the avail-
ability of nutrients induces cell–cell signals, which would include
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protein mediators (cytokines). To analyze this, we subjected two
different cell lines, HeLa (cervical cancer) and Rh4 (alveolar
rhabdomyosarcoma), to glucose deprivation and to treatment
with 2-deoxyglucose (2-DG), a glycolytic inhibitor (10). Super-
natants were then subjected to biotin label-based antibody ar-
rays, which detect a total of 1,000 proteins involved in a variety of
functions (SI Appendix, Materials Table). Because dead cells
release their content and serum interferes with arrays of secreted
proteins, we lowered serum, while selecting times with low
amounts of cell death (maximum of 10% cell death) (SI Ap-
pendix, Fig. S1A). Results of the arrays are shown in Datasets S1
and S2.
To identify pathways, rather than individual proteins subjected
to regulation upon starvation, we performed gene set enrichment
analysis (GSEA). This analysis revealed a number of biological
processes and molecular functions significantly regulated by
glucose deprivation or 2-DG (SI Appendix, Fig. S1 B and C and
Dataset S3). Selected proteins from these pathways, such as
interleukin-8 (IL-8) (gene name CXCL8), IL-6, CXCL1, and
TNFα, were confirmed to be regulated at the messenger RNA
(mRNA) level in HeLa (Fig. 1A and SI Appendix, Fig. S1D), and
glucose deprivation induced the mRNA of IL-6 and TNFα in
Rh4 cells (Fig. 1B). IL-6 and IL-8 were indeed secreted from
starved HeLa (Fig. 1C and SI Appendix, Fig. S1D). Importantly,
cytokine secretion was not exclusive of tumor cells, and we could
also observe the release of M-CSF, CXCL1, IL-6, and IL-8 from
primary pulmonary epithelial cells (HBTECs) upon glucose
deprivation (Fig. 1 D and E).
To detect more inflammatory cytokines that may have been
overlooked in the first array, we performed specific arrays for
immune cytokines and chemokines. To this end, we employed
A549 non-small cell lung adenocarcinoma (LUAC) cells, which
were less sensitive to glucose deprivation than HeLa or Rh4, thus
allowing the minimization of cell death in supernatants (SI Ap-
pendix, Fig. S1F). Chemokine and cytokine arrays revealed that a
number of immune cytokines and chemokines were also up-
regulated in A549 cells upon glucose deprivation (SI Appendix,
Figs. S1 J and K and S2 A–G and Dataset S4). Among them, we
found induction of chemokines like CXCL8 (IL-8), CCL5
(RANTES), CCL20 (MIP-3β), and CCL19, as well as immune
cytokines, including IL-6, IL-2, IL-11, M-CSF, and CD14. Cy-
tokines with other functions, like VEGF, CTGF, or adiponectin,
were also induced while some chemokines like CCL2 were down-
regulated. The mRNA coding for some of the proteins analyzed
peaked at 3 h and returned to nearly normal levels after 24 h
(Fig. 1 F–H and SI Appendix, Fig. S2 A–G), thereby showing a
different pattern than observed in HeLa cells (Fig. 1A). We
verified using enzyme-linked immunosorbent assay (ELISA) the
inducible synthesis and release of IL-6 and IL-8 whereas CXCL1
and M-CSF levels did not change in the supernatant (Fig. 1 I–K
and SI Appendix, Fig. S2H).
Given the functional relevance of IL-8 and IL-6 in cancer and
that these cytokines were consistently up-regulated, we focused
on the regulation of these two proteins to understand the sig-
naling pathways that promote their synthesis and secretion.
These cytokines are likely regulated differently, based on dif-
ferent kinetics of mRNA synthesis shown in Fig. 1. IL-8 showed a
much higher release than IL-6 from A549 (Fig. 1 I and J)
(Fig. 1 I and J), which allowed us to study its secretion at short
times within the ELISA detection range. IL-8 is involved in a
variety of physiological functions and pathologies, such as can-
cer. Notably, it is a proangiogenic factor, and it confers survival,
chemoresistance, and immunosuppressive function (11). We
verified that, even though its messenger peaked at 3 h (Fig. 1F),
the protein was continuously being synthesized and released at
longer time points, as previously observed in HeLa cells. Analysis
of protein content in the cell lysate indicated that IL-8 was being
secreted as it was synthesized (SI Appendix, Fig. S2 I–K).
Importantly, its secretion correlated inversely with the amount of
glucose present in the medium (SI Appendix, Fig. S2L). We ex-
tended the analysis of IL-8 and IL-6 secretion to other LUAC
cell lines, H460 and H1299, and to two squamous lung carcinoma
cell lines, H520 and SW900. These cell lines displayed hetero-
geneous sensitivity to glucose deprivation (SI Appendix, Fig. S1)
and heterogeneous patterns of cytokine release (SI Appendix,
Fig. S2 M–T), with H460 and SW900 showing a high constitutive
secretion of IL-6 and IL-8 that was further increased upon glu-
cose deprivation. H1299 and H520 did not secrete either cyto-
kine under basal or starved conditions, indicating that not all cell
lines exhibit the same pattern. These data indicate that starva-
tion promotes the induction of protumorigenic cytokines, which
prompted the question whether targeting cancer metabolism
might trigger the same response.
2-DG, Metformin, and Glutamine Depletion, but Not Complete Starvation,
Induce IL-6 and IL-8 Secretion. Drugs targeting cancer metabolism are
currently being used in clinical trials. 2-DG is an inhibitor of gly-
colysis and glycosylation frequently used to mimic glucose depriva-
tion that has been tested in patients (10, 12). Metformin targets
mitochondrial complex I and is being proposed as an anticancer
agent due to epidemiological observations of reduction of cancer
incidence, as well as due to associations between diabetes and cancer
prognosis (13, 14). We observed that, in general, 2-DG was not toxic
to HeLa or A549 cells in contrast to other cell lines that undergo cell
death with 2-DG added in the millimolar range (15) (SI Appendix,
Figs. S1A and S3A). Exposure to 2-DG in complete medium pro-
moted the induction of CXCL8 and IL-6 in A549 (Fig. 2A), release
of IL-6 from HeLa, A549, and H460 cells (Fig. 2B), and release of
IL-8 from HeLa and A549 (Fig. 2C), without promoting cell death.
Other cell lines that showed little or no cytokine induction upon
glucose deprivation did not secrete IL-8 upon treatment with 2-DG
(SI Appendix, Fig. S3 B and C), and primary HBTECs did not re-
spond to 2-DG in the same way than to glucose deprivation (SI
Appendix, Fig. S3D). Intriguingly, 2-DG prevented cell death of
glucose-deprived A549 cells, but it could not substitute for glucose in
terms of IL-8 release (SI Appendix, Fig. S3 E and F). This suggests
that 2-DG is partially metabolized and can contribute to some es-
sential metabolic or signaling pathway upon glucose depletion. This
phenomenon has been previously observed in other cancer cell lines
(16, 17).
Mannose, a glucose isomer that can substitute for glucose in
some cell lines or inhibit glucose metabolism in others (18, 19),
prevented both cell death and IL-8 release in these cells (SI
Appendix, Fig. S3 E and F). Metformin in the millimolar range
induced mRNA expression and cytokine release of IL-8 and IL-6
in both A549 and H460 cells (Fig. 2 D–F). In addition, glutamine
depletion also promoted IL-6 and IL-8 mRNA induction and
protein release, as previously described in other cell lines (7, 8).
Complete starvation through incubation in a saline solution,
Hanks’ balanced salt solution (HBSS), led to induction of
CXCL8 mRNA, but it did not lead to secretion of IL-6 or IL-8
(Fig. 2 G and H), indicating that different starvation stimuli lead
to different outcomes.
Glucose Deprivation Induces the Unfolded Protein Response (UPR)
and Promotes mTOR Inactivation. Glucose deprivation inactivates
mTORC1, in part through activation of AMPK (20). mTOR
inactivation down-regulates protein synthesis and other anabolic
pathways. Many tumors and cell lines, including A549, are de-
ficient for the kinase LKB1 that activates AMPK upon glucose
withdrawal. Fig. 3A shows mTORC1 inactivation upon glucose
deprivation in A549, possibly due to secondary loss of non-
essential amino acids. Since mTORC1 inactivation is a common
feature of most forms of starvation, we next evaluated whether
the use of mTOR inhibitors would be sufficient to promote cy-
tokine release. Rapamycin, an inhibitor of mTORC1, did not




















promote IL-8 release at doses that inactivate mTORC1 (Fig. 3B
and SI Appendix, Fig. S4A). Torin-1, which also inhibits
mTORC2, induced IL-8 (Fig. 3C and SI Appendix, Fig. S4B).
However, when combined with glucose deprivation, both inhib-
itors reduced cytokine release, indicating that mTOR was re-
quired for IL-8 release (Fig. 3 B and C), as described previously
in experiments of glutamine deprivation (7).
Another related outcome of starvation, which promotes mTOR
inactivation in a context-dependent manner, is the activation of
the UPR and/or the integrated stress response (ISR), which at-
tenuates 5′ cap-dependent protein translation. These responses
converge toward the phosphorylation of the translation initiation
factor eIF2α and are engaged upon endoplasmic reticulum (ER)
stress as part of the UPR, or upon amino acid/heme depletion and
Fig. 1. Inhibition of glycolysis promotes cytokine synthesis and secretion. (A) HeLa cells were treated for 8 or 24 h with media containing 25 mM (Glc+) or
2 mM (Glc−) glucose. qPCR for indicated genes is shown. Fold expression was calculated by normalizing to control sample Glc+ at 8 h. Data are represented as
mean ± SEM (n = 3). Asterisks denote significant differences between treated cells and the 8-h Glc+ sample for each mRNA. (B) Rh4 cells were treated and
analyzed for 8 or 20 h as in A. Data represent mean ± SEM (n = 3). Asterisks denote significant differences to the control sample at 8 h in Glc+ of each siRNA.
(C) HeLa cells were treated for 24 h with 25 mM or 0 mM Glc, and supernatants were analyzed by ELISA of TNFα, CXCL1, and IL-6. Data represent mean ± SEM
(n = 3). (D and E) HBTECs were treated for 24 h with media containing indicated glucose concentrations. Supernatants were analyzed by ELISA for M-CSF (D)
and IL-8, IL-6, and CXCL1 (E). Data represent mean ± SEM (n = 3). Asterisks represent significant differences between the 25-mM control sample and each
treatment analyzed by one-tailed paired t test. (F–H) A549 cells were treated for 1, 3, 6, 16, and 24 h with media containing 25 (Glc+) or 0 mM (Glc−) glucose.
qPCR of CXCL8 (F), IL-6 (G), CXCL1 (H) is shown. Fold expression was calculated by normalizing to cells treated for 6 h with Glc+. Data are represented as mean ±
SEM (n = 3–9). Asterisks denote significant differences versus the samples in Glc+ for each time point analyzed by two-way ANOVA. (I–K) A549 cells were treated as
in F for indicated time points. ELISA of IL-8 (I), IL-6 (J), and CXCL1 (K) is shown. Data are represented as mean ± SEM (n = 3–4). Asterisks denote significance
between the Glc+ and Glc− sample for each time point analyzed by two-way ANOVA. Error bars represent the SEM. The significance was indicated as follows: *P <
0.05; **P < 0.01; ***P < 0.001.








































viral double-stranded RNA (dsRNA) detection as part of the ISR.
Glucose deprivation engages both the UPR and the ISR in mul-
tiple cell lines, depending on activation of the kinases PERK or
GCN2, respectively, which phosphorylate eIF2α (21–23). Phos-
phorylation of this translation initiation factor is mainly involved
in translational attenuation which in turn may result in selective
translation of certain mRNA, including that encoding the tran-
scription factor ATF4. This transcription factor targets the ex-
pression of metabolic genes whose products restore cell
homeostasis. But ATF4 also promotes cell death upon glucose
deprivation or 2-DG (15, 18). GCN2 was shown to be required for
the induction of ATF4 upon glucose deprivation in A549 cells
(23). Analysis of ATF4 expression in these cells revealed the fast
(3 h) accumulation of this protein upon glucose starvation
(Fig. 3D and SI Appendix, Fig. S4C), a time in which we could also
detect a strong induction of one of its target genes, CHOP (SI
Appendix, Fig. S4D). Besides activation of GCN2, possibly by
uncharged transfer RNA, it is likely that glucose-deprived cells
activate the UPR because they undergo ER stress in the absence
of sugar derivatives required for N-glycosylation. In this sense,
XBP1 mRNA splicing was also detected at short times (Fig. 3E
and SI Appendix, Fig. S4E). Since the endoribonuclease re-
sponsible for XBP1 mRNA splicing (IRE1) and XBP1 have pre-
viously been involved in cytokine synthesis in immune cells and
animals subjected to restrictive diets (24, 25) or in cytokine release
by cancer cells (26, 27), we analyzed their role in cytokine syn-
thesis. The use of a chemical inhibitor of IRE1α RNase activity,
MKC-8866, prevented XBP1 splicing, but not CXCL8 induction
(Fig. 3F). Silencing of XBP1 with two different small interfering
RNA (siRNA) sequences reduced the level of XBP1s and its
downstream target Erdj4. However, IL-8 was not consistently
down-regulated (SI Appendix, Fig. S4 G–I). In summary, the
IRE1/XBP1 pathway does not play a relevant role in IL-8 in-
duction in our experimental settings.
ATF4 and NF-κB Mediate Cytokine Induction and Release. Glucose
deprivation, 2-DG, and metformin induced ATF4 (Fig. 3D and
SI Appendix, Fig. S5 A–C). A role for ATF4 in cytokine induction
and secretion upon glucose deprivation was investigated by using
siRNA. HeLa cells transfected with siRNA against ATF4
showed less accumulation of the mRNA of three cytokines
tested: CXCL1, CXCL8 (IL-8), and IL-6 (Fig. 4 A–C and SI
Appendix, Fig. S5D). In A549 cells, the use of two different
siRNAs against ATF4 showed that CXCL8 expression and IL-8
secretion were ATF4-dependent (Fig. 4 D and E and SI Appendix,
Fig. S5E). Moreover, quantitative DNA-protein interaction ELISA
(qDPI-ELISA) and chromatin immunoprecipitation analysis un-
veiled that CXCL8 is a direct target of ATF4 (Fig. 4 F andG and SI
Appendix, Fig. S5G; see promoter scheme in SI Appendix, Fig. S5F).
Similar results were obtained when analyzing IL-6, which is an
ATF4 target in macrophages (28), and CXCL2 (Fig. 4 H–J). The
use of a chemokine array allowed us to detect other chemokines
regulated by ATF4, like CCL2 and CXCL5 (SI Appendix, Fig. S5 H
and I). CCL2 was down-regulated by glucose deprivation, and its
levels were recovered by silencing ATF4 (SI Appendix, Fig. S5J).
CXCL5 was secreted in high quantities by A549 cells, and its
mRNA was regulated by ATF4, in the presence or absence of
glucose, although the reduction of the protein in cell supernatants
was not significant (SI Appendix, Fig. S5 K and L). Other cytokines
and chemokines like CXCL3 were only mildly or not regulated by
ATF4 (SI Appendix, Fig. S5 N–Q).
Inflammatory cytokines and chemokines are generally regu-
lated by the transcription factor NF-κB. This transcription factor is
activated downstream of the UPR/ISR via multiple mechanisms
Fig. 2. 2-DG, metformin (Met), and glutamine deprivation induces IL-6 and IL-8. (A) A549 cells were treated with 2-DG for 6 h. qPCR for CXCL8 and IL-6 is
shown. Values were normalized to control sample at 0 mM 2-DG. Data are represented as mean ± SEM (n = 3–4). Asterisks denote significant differences with
the 0-mM sample for each cytokine. (B and C) A549, HeLa, and H460 cells were treated with 2-DG for 24 h at indicated concentrations. ELISA values for IL-6 (B)
and IL-8 (C) are shown. Data represent mean ± SEM (n = 3–4). Asterisks denote significant differences versus the 0-mM control sample for each cell line. (D)
A549 cells were treated for 6 h with metformin at indicated concentrations. qPCR for CXCL8 and IL-6 is shown. Values are normalized to cells treated without
the drug. Data are represented as mean ± SEM (n = 4). Asterisks denote significant differences versus the 0-mM control sample. (E and F) A549 and H460 cells
were treated for 24 h as in D. ELISA is shown for IL-8 (E) and IL-6 (F). Data are represented as mean ± SEM (n = 3). Asterisks denote significant differences vs.
the control for each cell line. (G) A549 cells were incubated in 25 mM (Glc+) glucose, 0 mM glutamine (Gln−) medium or HBSS for 6 h. qPCR is shown for CXCL8
and IL-6. Values were normalized to Glc+. Data represent mean ± SEM (n = 3). Asterisks denote significant differences vs. Glc+. (H) A549 cells were incubated
with Glc+, Gln− medium, or HBSS for 24 h. ELISA is shown for IL-8 and IL-6. Data indicate mean ± SEM (n = 3–4). Asterisks denote significant differences versus
Glc+. Error bars represent the SEM. The significance was indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001.




















which include IRE1-mediated TRAF/JNK activation and degra-
dation of IκB when translation is reduced (29). Down-regulation
of p65, one of the canonical NF-κB subunits, using siRNA, in-
dicated that IL-8 was regulated at the mRNA and protein level
upon glucose deprivation and also in basal conditions in A549 cells
(Fig. 5 A, B, D, and E). Similarly, silencing p65 reduced IL-6 in-
duction and secretion (Fig. 5 C and F). p65 NF-κB participated in
regulation of the mRNA of M-CSF, CXCL1, CXCL2, and CCL20
(SI Appendix, Fig. S6 C–F) while the effect on CXCL3 and
CXCL5 was minor (SI Appendix, Fig. S6 G and H). NF-κB was
also required for induction of CXCL8, CXCL1, and IL-6 in HeLa
cells (Fig. 5 G–I and SI Appendix, Fig. S6 A and B).
We investigated a possible cross-talk between ATF4 and NF-
κB in the regulation of IL-8 and found that inhibition of NF-κB
using BAY 11-7082 or silencing p65 did not alter ATF4
induction (Fig. 5 J–L and SI Appendix, Fig. S6 I–K) and silencing
ATF4 had only a minor effect on IκBα degradation (SI Appendix,
Fig. S6 L–N). In summary, a subset of immune cytokines and
chemokines is induced transcriptionally and translationally by
NF-κB p65 and/or ATF4 during glucose deprivation.
Conditioned Medium from Starved Cells Promotes Paracrine Effects
on Cancer Cells. The pattern of cytokine induction was conserved
among multiple cancer cell types and even nontransformed cells.
This suggests that this is a conserved response that may play
wound healing or alarm roles in the tissue and which could in-
fluence the cross-talk between cancer cells and the stroma. Ad-
ditionally, our results suggested the possibility that proteins
secreted from cancer cells subjected to starvation protect
neighboring cancer cells or stimulate their own migration. To
test which roles could the cytokine mixture play, we collected
conditioned medium from A549 cells subjected to glucose dep-
rivation or grown in control medium. A fraction of the condi-
tioned medium was filtered and washed with fresh medium to
concentrate the cytokines and eliminate metabolites secreted
from starved cells (see scheme in SI Appendix, Fig. S7A). The
conditioned medium was applied to the lower part of a Boyden
chamber in which A549 cells were plated on top, and migration
was measured. We observed that A549 cells migrate toward
conditioned media. However, there was no major difference in
the migration between the conditioned media from cells grown
in the presence or absence of glucose (SI Appendix, Fig. S7 B and
C). We also incubated A549 cells in conditioned media and
measured cell death induced by glucose deprivation. Filtered
conditioned media without glucose, containing secreted cyto-
kines but not metabolites, induced more cell death than control
media without glucose (SI Appendix, Fig. S7 D and E), and it did
not promote epithelial–mesenchymal transition (EMT) or
matrigel invasion (SI Appendix, Fig. S7 F–I). However, the fac-
tors released by starved cells changed A549 adhesion in collagen
and stimulated their proliferation (Fig. 6 A and B). A predicted
effect of the conditioned medium, according to the cytokines
secreted, was angiogenesis. We tested the effects of conditioned
medium on human umbilical vein endothelial cells (HUVECs)
and observed that the fraction larger than 3 kDa from starved
A549 cells stimulated their proliferation and migration com-
pared to medium from nonstarved cells (Fig. 6 C and D)
Conditioned Medium from Starved Cells Promotes Migration of
Immune Cells. Inflammation occurs during wound healing, and
it involves the recruitment of immune cells to injured or infected
sites. Our results suggested that glucose deprivation could pro-
mote a similar response. We first tested whether conditioned
medium from starved A549 cells would stimulate migration of
lymphoid cells from healthy donors. Cells incubated in Boyden
chambers showed a tendency to migrate more toward condi-
tioned medium from starved cells than to medium from control
cells. This tendency was conserved when the conditioned me-
dium was filtered and washed. The trend was observed for T
lymphocytes (CD3+), natural killer T cells (CD3+ CD56+), and
natural killer cells (CD3− CD56+), but not for monocytes
(Fig. 6E and SI Appendix, Fig. S7 J–L), and was more obvious
and significant for B cells (CD19+) (Fig. 6F).
The known roles of some of the chemokines studied include
chemoattraction of myeloid cells. We performed migration ex-
periments using THP-1 cells differentiated to macrophage-like
cells using phorbol 12-myristate 13-acetate (PMA). We observed
a higher migration toward conditioned media of starved cells
regardless of glucose availability (Fig. 6G). Moreover, migration
was not due to secreted metabolites (Fig. 6G, blue) but due to
the fraction larger than 3 kDa, which also induced migration of
THP-1 when replenished with fresh complete media.
Fig. 3. Glucose deprivation induces the UPR and promotes mTORC1 in-
hibition. (A) A549 cells were treated for 1, 3, 6, 16 and 24 h in media con-
taining 25 mM (Glc+) or 0 mM (Glc−) glucose. A representative Western blot
for pAMPK, pS6, and 4E-BP1 is shown. Protein bands were quantified and
normalized to actin; numbers underneath each image represent normalized
band intensity. (B and C) Cells were treated for 24 h with rapamycin (Rapa)
(B) or Torin1 (C) in media containing 25 mM (Glc+) or 0 mM (Glc−) glucose.
ELISA of IL-8 was performed. Data are represented as mean ± SEM (n = 3–4).
Asterisks denote significant differences of rapamycin- or torin-treated cells
versus the drug-free sample for each culture medium. (D) Cells were treated
for indicated times with 25 mM glucose (C) or 0 mM (Glc−). A representative
Western blot (n = 3) for ATF4 and CHOP is shown. Protein bands were
quantified and normalized to actin. (E) Cells were treated as described in D
or for 24 h with 4 μM thapsigargin (Tg) and lysed for mRNA extraction.
Retrotranscription was performed followed by RT-PCR for XBP1. Represen-
tative PCR is shown out of 3. (F) Cells were pretreated with 10 μM of the IRE-
1 inhibitor MKC-8866 for 16 h and for another 6 h in combination with
media containing 25 mM (Glc+) or 0 mM (Glc−) glucose. XBP1s and CXCL8
mRNA was analyzed by qPCR. Values are normalized to the Glc+ control
sample of each treatment. Data show mean ± SEM (n = 3). Error bars rep-
resent the SEM. The significance was indicated as follows: *P < 0.05.








































The first responders to an injury site are neutrophils. We
differentiated HL60 cells to neutrophil-like cells and observed
that, although they do not migrate toward conditioned media of
A549 (SI Appendix, Fig. S7M), conditioned media from starved
H460 cells, which release higher amounts of cytokines (SI Ap-
pendix, Fig. S2), attracted HL60 cells (Fig. 6H). We also purified
neutrophils from human blood and let them migrate toward
conditioned media of A549 or H460 cells. Primary neutrophils
migrated preferentially toward conditioned media from starved
cells (Fig. 6I and SI Appendix, Fig. S7N). These media did not
promote differential effects on cell death or activation of neu-
trophils (SI Appendix, Fig. S7 O and P). Additionally, we injected
conditioned medium from murine CT26 cells in the peritoneal
cavity of syngeneic immunocompetent mice. The conditioned
medium was collected from cells that had been incubated in the
presence or absence of 2-DG. Afterward, the conditioned media
were washed with fresh media to remove 2-DG. Forty-eight hours
after the injection, the number of macrophages and neutrophils
retrieved was higher in mice injected with the 2-DG conditioned
medium (Fig. 7A) although the effect was lost at 72 h (SI Ap-
pendix, Fig. S8).
Finally, we tested whether ATF4 and p65 played a role in the
paracrine effects of conditioned media and whether some of the
migratory effects were mediated by IL-8 and/or IL-6. We verified
that neutralization of IL-6 or IL-8 affected migration of THP-1
cells or neutrophils while silencing p65 or ATF4 reduced mi-
gration of CD19+, neutrophils, and macrophage-like THP-1 cells
(Fig. 7 B–E).
Discussion
Nutrient limitation occurs during physiological tissue growth or
as a consequence of various pathological events, such as wounds
or vascular occlusions that lead to transient ischemia. To re-
cover, ischemic tissues employ mechanisms that promote wound
healing and the restoration of the nutrient flux. These mecha-
nisms include angiogenesis and inflammation, which have been
classically attributed to hypoxia or to necrotic inflammatory
signals, respectively. We show here that nutrient deprivation
could be, by itself, a powerful signal to induce inflammation as
part of a normal wound-healing response as pathogens and sterile
injuries trigger similar events which include the recruitment of the
innate immune system. It is possible that nutrient deprivation
followed by the ISR is one of the many signals that the body uses
to detect infections as pathogens also deprive nutrients from the
site of infection. In fact, the kinase PKR, that detects viral dsRNA,
is one of the kinases that activate the ISR (30).
In cancer, starvation can occur in three major scenarios.
During tumor growth, the rapid expansion of tumor cells results
in poor vascularization. Second, some oncogenes promote the
massive use of nutrients, which create a state of “pseudo-
starvation” that has been proposed to contribute to metastasis
(31). Third, antimetabolic drugs being used or tested for cancer
therapy cause starvation-like signals in cancer cells. Given the
role of several of the cytokines described here in tumor pro-
gression, our results suggest a note of caution when treating
patients with these drugs. On the other hand, tumorigenic pro-
gression is often associated to chronic inflammation. Our data
suggest that one of the major promoters of tissue inflammation
in tumors may be the lack of nutrients, which induces the se-
cretion of chemokines and cytokines that in turn may promote
tumor survival through suppressive immune infiltration.
We performed RNA and protein arrays in several cell lines
and confirmed that glucose deprivation leads to the induction
and release of a broad range of proteins, such as VEGF and IL-
8, that are associated with angiogenesis, or IL-6 and IL-11, that
promote tumor growth and survival. Paracrine signaling could
transmit noncell autonomous “adaptation to stress” signals to
neighboring cells to promote escape or adapt to the nutrient
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Fig. 4. ATF4 regulates cytokine mRNA and secretion in HeLa and A549 cells. (A–C) HeLa cells were transfected for 24 h with nontargeting siRNA (labeled as
‘’C” for Control siRNA) or siRNA against ATF4 (labeled “A#1” for ATF4 sequence 1). After 24 h, cells were washed and incubated in 25 (Glc+) or 2 mM glucose
(Glc−) media. qPCR for CXCL8 (A), IL-6 (B), and CXCL1 (C) is shown. Data are represented as mean ± SEM (n = 3). Fold expression was calculated by normalizing
to the control siRNA in Glc+ conditions or time = 0 (T0) (before treatment). Asterisks denote significant differences of ATF4-transfected cells versus the control
siRNA in each culture medium. N.S. means not significant. (D, E, and H–J). A549 cells were transfected for 40 h as described in A as well as with siRNA against
ATF4 (labeled “A#2” for ATF4 sequence 2) and treated with 25 mM (Glc+) or 0 mM (Glc−) glucose for 6 h (D, H, and J) or 24 h (E and I). qPCR data for CXCL8 (D),
IL-6 (H), and CXCL2 (J) were normalized to the control siRNA of Glc+. ELISA is shown for IL-8 (E) and IL-6 (I). Data are represented as mean ± SEM (n = 3–5).
Asterisks denote significant differences of ATF4-transfected cells versus the control siRNA in each culture medium. (F and G) A549 cells were treated for 6 h
with 25 mM (Glc+) or 0 mM (Glc−) glucose (F), or with 25 mM glucose and 10 ng/mL TNFα (G). Cells were harvested and processed for qDPI-ELISA as described in
SI Appendix for ATF4 (F) and p65 (G). Values represent mean ± SEM after normalization to the value of halfCRE-containing oligo Glc+ (F, n = 4) or average of
optic density values (OD) (G, n = 2). Asterisks indicate significant differences by two-way ANOVA. Error bars represent the SEM. The significance was indicated
as follows: *P < 0.05; **P < 0.01.




















shortage and overcome the starvation. Interestingly, some cyto-
kines, like IGFBP-2, or chemokines, like CXCL5 and CCL2,
were down-regulated upon glucose deprivation even if their
mRNA was induced, which was the case of TNF. This could be
due to impaired N-glycosylation in the absence of glucose, and it
should be tested under other starvation conditions that do not
impair this protein modification.
Focusing on chemokines and cytokines involved in in-
flammation, we found IL-8 and IL-6 as proteins consistently
secreted from different cell lines (HeLa, A549, H460, and
SW900), indicating that the response is conserved among distinct
cancer cell types. Some cells analyzed here showed high basal
levels of IL-6 and IL-8 (H460, SW900), which has been attrib-
uted to their mutations in KRAS (32). IL-8 promotes angio-
genesis, metastasis, and proliferation in lung cancer, and it is also
a chemoattractant for neutrophils. Higher levels of circulating
IL-8 are associated with poor prognosis and overall survival of
non-small cell lung cancer patients (32). IL-6 is well-described as
an activator of tumor-associated signaling cascades promoting
tumor growth, immune cell infiltration, and cachexia (33). This
suggests that induction of IL-6 and IL-8 by starvation signals
present in poorly irrigated tumors may worsen patient outcome.
Glucose deprivation induces ER stress and the UPR, fre-
quently due to the lack of flux through the glucosamine pathway,
which impairs N-glycosylation. In some cell lines, the UPR and cell
death can thus be prevented by readdition ofN-acetylglucosamine and
substrates for glycosylation, like mannose. In A549 cells, mannose
prevented cell death and IL-8 induction, but N-acetylglucosamine did
not, which suggests, in accordance to a previous report, that another
pathway than the PERK-driven UPR might activate ATF4 in
A549 cells (23). In parallel, however, we have observed activa-
tion of the ER stress sensor IRE1, which mediates immune in-
filtration in cancer. In our experimental conditions, we could not
detect the involvement of the IRE1–XBP1 pathway in IL-8 in-
duction, but its effects on the overall response to starvation
should be tested more extensively by analyzing other cytokines.
ATF4 had been previously found to mediate IL-6 induction upon
metabolic stress in macrophages and human tumor cells (3, 28),
as well as VEGF induction (3, 4, 34). In A549, we observed that
ATF4 was induced upon treatment with all starvation-promoting
stimuli, and it was linked to cytokine production. IL-6 and IL-8
Fig. 5. The p65 NF-κB subunit regulates cytokine synthesis and secretion. (A–F) A549 cells were transfected for 40 h with control nontargeting siRNA (labeled
as “C”) or siRNA for p65 (labeled as “p#1” for sequence 1 and “p#2” for sequence 2). Western blot of p65 is shown in A. Cells were subsequently incubated
with media containing 25 mM (Glc+) or 0 mM (Glc−) glucose for 6 h (B and C), for 16 and 24 h (D), or for 24 h (E and F). qPCR for CXCL8 (B) or IL-6 (C) was
performed. Values were normalized versus control siRNA in Glc+. IL-8 (D and E) and IL-6 (F) were analyzed by ELISA. Results show mean ± SEM (n = 3–4).
Asterisks denote significant differences of p65-transfected cells versus the control siRNA in each culture medium. N.S. means not significant. (G–I) HeLa cells
were transfected for 24 h with siRNA (as in A) and treated for 24 h with 25 mM (Glc+) or 2 mM (Glc-) glucose. qPCR for CXCL1 (G), IL-6 (H) and CXCL8 (I) is
shown. Values are normalized versus the control siRNA in Glc+. Results show mean ± SEM (n = 4). Asterisks denote significant differences of p65-transfected
cells versus the control siRNA in each culture medium. (J–L) A549 cells were treated with the NF-κB inhibitor (BAY11-7082 [BAY]) at concentrations shown with
media containing 25 mM (Glc+) or 0 mM (Glc−) of glucose for 16 h. Western blot of ATF4 and IκBα is shown in J. ATF4 (K) (n = 4) was quantified and normalized
to actin. Fold induction was calculated vs. Glc− control sample. IL8 (L) was analyzed by ELISA after treating as in J. Results show average ± SEM (n = 4). Asterisks
denote significant differences of treated cells vs. the 0-mM control of each of the culture media. Error bars represent the SEM. The significance was indicated
as follows: *P < 0.05; **P < 0.01; ***P < 0.001.








































contain CRE/ATF4 binding sites in their promoters, and we
describe here that ATF4 binds the IL-8 (CXCL8) promoter, so it
is possible that ATF4 acts directly as a transcription factor of
several of the cytokines. However, it could also be working in
combination with NF-κB or CHOP, which have been shown to
participate together in the induction of IL-8 transcription upon
infection (35), or indirectly on some of the cytokines. Moreover,
nutrients regulate epigenetic modifiers that could be contribut-
ing to rewiring transcriptional pathways under nutrient scarcity
(36). On the other hand, glucose deprivation inactivates
mTORC1 in our setting. While in some cells the mTORC1 in-
hibitor rapamycin has been shown to induce IL-6, suggesting that
this would be the cause for cytokine induction (9), our experi-
ments and those from others indicate that some mTORC1 ac-
tivity is required for cytokine secretion (7). Enhanced translation
of specific genes during the UPR/ISR may also be contributing
to promote synthesis of the cytokines (8). The transcriptional
and translational links between mTOR, the UPR/ISR, and
starvation are, however, far from simple, and more experiments
should be performed to establish the precise role for each sig-
naling pathway in the regulation of each cytokine upon different
forms of starvation.
Several recent reports indicate that the metabolic rewiring of
tumors interferes with antitumor immunity in many ways
(reviewed by ref. 37). On one hand, tumor-derived metabolites,
such as lactate or adenosine, influence the immune response. On
the other hand, in the tumor microenvironment low in glucose,
immunity is impaired due to a “metabolic competition” between
the tumor and the T cells (38, 39). However, not only T cells are
affected: The innate immune system could also play a role in
immune escape. In this sense, tumor hypoxia rewires tumor-
associated macrophages (40), and our data suggest that low
nutrients could be promoting macrophage and neutrophil at-
traction. It was also shown that inhibition of glycolysis in the
tumor by using 2-DG in vitro or silencing lactate dehydrogenase
A in vivo prevents the secretion of a cytokine required for the
development of myeloid-derived suppressor cells, which have yet
to be analyzed in the starvation settings used in our study (41).
Since tumor-intrinsic factors, including chemokines, are often
responsible for the differences of a T cell inflamed versus an
inflammatory suppressor environment (42), we propose that
cell–cell effects of cancer starvation are one of the suppressive
factors impairing immune activity. In summary, our data indicate
that nutrient shortage promotes a response that resembles
wound healing. This response could be required to coordinate
Fig. 6. Conditioned (cond) medium promotes migration of immune cells and HUVECs. (A) A549 cells were pretreated for 16 h with conditioned (yellow) or
washed conditioned (orange) media derived from other A549 cells which were cultured for 24 h with 25 (+) or 0 (−) mM glucose. Fresh Glc was added when
indicated. Cells were harvested and plated in a collagen-coated plate, and attached cells were counted by crystal violet. Results were normalized to each Glc+
control and show mean ± SEM (n = 4). Asterisks denote significant differences between each pair. (B and C) A549 (B) and HUVECs (C) were cultured for 24 h
with media containing 25 mM glucose or with washed conditioned (orange) media of other A549 cells which were cultured as described in A; 10% FBS was
added in all conditions. Fresh Glc was added when indicated. Proliferation was measured by crystal violet staining. Values were normalized to cells cultured in
fresh glucose containing media (white bar). Results show mean ± SEM of A549 (n = 6) and HUVEC (n = 7) experiments. Asterisks denote significant differences
using one-tailed (A549) or two-tailed (HUVEC) t test as indicated. (D) HUVECs were allowed to migrate for 16 h toward washed conditioned (orange) media
derived from A549 cells treated as in A. Fresh Glc was added when indicated. Migrated cells were stained by crystal violet and counted by ImageJ. Results
show mean ± SEM (n = 4). (E and F) Human PBMCs were allowed to migrate for 20 h toward fresh glucose-containing (25 mM) or glucose-free medium (white
bars), or conditioned media (yellow bars) from A549 cells grown in glucose-containing or glucose-free medium for 24 h. Conditioned media which were
refreshed are designated in orange, and elution in blue (SI Appendix, Fig. S7). Migrated cells were stained for indicated markers and analyzed by
fluorescence-activated cell sorter (FACS). Data are represented as mean ± SEM. CD3− CD56+ (n = 5–7) and CD19+ (n = 6–9). The dashed line indicates the level
of basal migration in fresh Glc+ medium. Asterisks denote significant differences between cells migrated toward the Glc+ control sample (white bar) or as
indicated. (G) THP-1 cells were differentiated, allowed to migrate for 20 h toward media as described in E, and counted. Data are represented as mean ± SEM
(n = 3–4). Asterisks denote significant differences of cells migrated toward fresh Glc+ and conditioned media or as indicated. (H) HL60 cells were differentiated
and cells migrated for 2 h toward fresh (white bars) or conditioned media of H460 cells (yellow bars) which were grown for 24 h in media containing 25 (+) or
0 (−) mM glucose and 2% FBS. "−/+" indicates conditioned, glucose-free medium to which 25 mM glucose was added before the experiment. Data represent
mean ± SEM (n = 3). Asterisks denote significant differences of cells migrated toward fresh Glc− media using one-tailed Student t test. (I) Neutrophils were
extracted from human blood and allowed to migrate for 1 h toward conditioned media as described in H. Data are represented as mean ± SEM (n = 6).
Asterisks denote significant differences versus Glc+. Error bars represent the SEM. The significance was indicated as follows: *P < 0.05; **P < 0.01.




















tissue repair after an episode of ischemia, but, in the case of
cancer, it could contribute to maintenance of the tumor.
Methods
Cell Lines and Human-Derived Primary Cultures. Human blood samples (buffy
coats) were obtained from the Banc de Sang i Teixits (BST) (Blood and Tissue
Bank). Experiments were approved by the Clinical Research Ethical Com-
mittee from the Hospital of Bellvitge (Comitè d’Ètica d’Investigació Clínica
[CEIC]). Isolation of peripheral blood mononuclear cells (PBMCs) and neu-
trophils was performed immediately after arrival of buffy coats, and primary
cultures did not exceed 24 h, including experiments. Primary immune cells
were cultured in pyruvate-free Dulbecco’s modified Eagle’s medium (DMEM)
containing 25 mM glucose, decomplemented 10% fetal bovine serum (FBS)
(heated at 57 °C for 30 min), and 2 mM fresh L-glutamine at 37 °C and 5%
CO2 atmosphere. Primary endothelial cells (HUVEC/TERT) were cultured in
EGMTM-2 Endothelial Cell Growth Medium-2 BulletKit containing additional
10% FBS. Primary bronchial/tracheal epithelial cells (HBTECs) were cultured
in Airway Epithelial Cell Basal Medium supplemented with the Bronchial
Epithelial Cell Growth Kit at 37 °C and 5% CO2 atmosphere.
Different cancer cell lines (lung: A549, H1299, H460, H520, SW900; cervix:
HeLa; rhabdomyosarcoma: Rh4; and leukemia: HL60) were cultured in DMEM
supplemented as for immune cells. Cells were maintained at 37 °C and 5%
CO2 atmosphere, and adherent cells were split twice a week when they
reached 90% confluence using a 0.05% trypsin ethylenediaminetetraacetic
acid solution. THP-1 (leukemia) cells were grown in RPMI supplemented with
10% FBS and 1% L-glutamine and diluted once a week with fresh RPMI at a
ratio of 1:20. Cells were grown in antibiotic-free medium.
Cell Treatments. Cell treatments were performed by plating 300,000 (6-well
plate) or 150,000 (12-well plate) cells 24 h prior to treatment. At a conflu-
ence of 80%, cells were washed twice with pyruvate-free DMEM, 0 mM
glucose, and 0% FBS, and glucose-deprived cells were treated with pyruvate-
free DMEM containing 0 mM glucose, 10% dialyzed FBS, and 1% L-gluta-
mine while the control cells were supplemented with glucose at concen-
trations indicated in the figures. For FBS dialysis, the dialyzing membrane
was washed according to the manufacturer’s recommendations and filled
with 100 mL of heat-inactivated FBS. The pipe was washed twice for 1 h and
once overnight in 1 L of PBS at 4 °C while stirring. Dialyzed FBS was sterilized
by using a 22-μm syringe filter.
For other treatments, cells were incubated in pyruvate-free DMEM with
25 mM glucose, 10% FBS, and 1% L-glutamine, unless indicated. For HBSS
treatments, cells were washed twice and incubated in HBSS with calcium,
magnesium and glucose 5.5 mM. For glutamine free treatments, cells were
washed twice with glutamine-free, pyruvate-free DMEM containing 10%
FBS and incubated with this medium.
Statistical Analysis. The significance of the data was calculated using the two-
tailed, paired Student’s t test unless indicated differently. Two-way ANOVA
followed by Sidak’s multiple comparison test was performed using Prism
GraphPad. Error bars represent the SEM. The significance was indicated as
follows: P < 0.05, one asterisk (*); P < 0.01, two asterisks (**) ; P < 0.001,
three asterisks (***). N.S. means not significant.
For detailed materials and methods, see SI Appendix.
Data Availability Statement. All data are included in the manuscript and
supporting information.
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